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Abstract
Early intra-abdominal infection (IAI) following pancreaticoduodenectomy (PD) is an initial event re-
lating to morbidities caused by postoperative pancreatic fistula (POPF). The aims of this study 
were to determine factors associated with IAI, and to investigate its impact on postoperative out-
come.
Consecutive patients, 113 in total, who underwent PD at Fukushima Medical University Hospital 
between January 2012 and September 2017 were included in this retrospective study. IAI was de-
fined by positive bacterial culture from intra-abdominal drainage fluid any time through postopera-
tive day 3 (POD3). Logistic regression analysis was used to identify the relevant factors associated 
with IAI. The clinical impact of the POD3 infection indicators related to POPF were assessed by 
multivariate analysis.
The incidence of IAI, POPF, and mortality were 36.1%, 36.1%, and 0%, respectively. Independent 
factors associated with IAI were preoperative biliary drainage (PBD) (OR=2.91, CI=1.16-7.33, 
p=0.023) and soft pancreas (OR=8.67, CI=2.37-31.77, p=0.001). Among infection markers on 
POD3, the significant factors for POPF were CRP (OR=1.18, CI=1.08-1.30, p<0.001), IAI 
(OR=7,37, CI=2.53-21.5, p<0.001), and drain amylase (OR=1.00, CI=1.00-1.01, p=0.001).
In conclusion, PBD, soft pancreas, and higher age were associated with IAI. IAI has a significantly 
negative impact on postoperative outcome.
Key words : pancreaticoduodenectomy, postoperative pancreatic fistula, surgical site infection, ear-
ly intra-abdominal infection, preoperative biliary drainage
Introduction
With advances in surgical techniques and peri-
operative management, pancreaticoduodenectomy 
(PD) has become a relatively safe procedure at high-
volume centers1). Postoperative mortality follow-
ing PD has been reduced to less than 5%2) ; howev-
er, morbidity remains high, with rates of 30-50%3,4), 
and is especially high in patients over 80 years of 
age5). Among the most important risk factors for 
postoperative morbidity is postoperative pancreatic 
fistula (POPF), which can lead to life-threating sur-
gical site infections (SSI) such as intra-abdominal 
abscess and/or postoperative hemorrhage due to 
pseudoaneurysm rupture.
Several reports have attributed various patient 
characteristics, intraoperative factors, or periopera-
tive management to the development of clinically 
relevant POPF2,6). Considering how serious com-
plications may arise from POPF, both early intra-ab-
dominal infection and leakage of pancreatic juice 
from the cut surface of the pancreas must coexist 
initially. Behrman et al. demonstrated that infected 
fluid may accumulate relatively early in the postop-
erative course, often containing more than one bac-
terial species7). Previous studies investigating 
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routes of intra-abdominal infection following PD 
have identified bacterial contamination of the lavage 
fluid during surgery8) or bacterobilia9) as triggers of 
POPF. However, there are a paucity of studies 
about contributing factors for developing IAI. Ad-
ditionally, much remains to be understood regarding 
the impact of IAI on subsequent postoperative com-
plications. In decision making for infection control 
practices following PD in the early postoperative 
course, understanding how much IAI impacts on 
POPF should be essential. Collectively, the aims of 
this retrospective study were to identify the factors 
associated with IAI following PD, as well as to evalu-
ate the impact of IAI on postoperative outcome in 
patients undergoing PD.
Methods
This retrospective, single-center cohort study 
was approved by the ethics committee of Fukushima 
Medical University, which is guided by local policy, 
national law, and the World Medical Association Dec-
laration of Helsinki (Approval number : 3040).
Study population
Consecutive patients who underwent PD at Fu-
kushima Medical University Hospital between Janu-
ary 2012 and September 2017 were enrolled in the 
present study. Patients who had pancreaticojeju-
nostomy with internal drainage of the pancreatic 
duct using a lost stent were excluded. Demograph-
ics, comorbidities, laboratory data including physio-
logical function tests, tumor pathology, and perioper-
ative data were collected for all patients.
Technique of pancreaticoduodenectomy and periopera-
tive management
Patients with objective jaundice due to Pancre-
atric, bile duct, or periampullary neoplasm were ini-
tially treated at a community hospital with biliary 
drainage, including endoscopic retrograde biliary 
drainage (ERBD) and percutaneous transhepatic bili-
ary or gallbladder drainage (PT[G]BD).
For the operative procedure, the incision was 
wrapped with a wound protector (Alexis Wound Re-
tractor ;  Applied Medical, Rancho Santa Margarita, 
CA, USA). After dissection of the bile duct, the 
stump was clamped to avoid spillage of bile juice.　
Pancreatic texture was assessed intraoperatively by 
palpation, as described in a previous study10). Pan-
creaticojejunostomy was performed in all patients 
using two-layer duct-to-mucosa anastomosis ; the 
modified-Kakita method11) with external drainage of 
the pancreatic duct by a stent. Ante-colic loop gas-
trojejunostomy was performed, and before wound 
closure, the abdominal cavity was lavaged with 6,000 
mL of warm saline. One or two closed-suctioned 
drainage tubes were routinely placed around the 
pancreaticojejunal anastomosis. All patients re-
ceived second- or third-generation cephem antibiot-
ics prophylactically every 3 hours during surgery, 
which was continued until postoperative day 3 
(POD3). Perioperative management was per-
formed according to a clinical pathway designed by 
our department. No patient received thromboem-
bolic prophylaxis with low-molecular-weight hepa-
rin.
Peripancreatic drainage fluid was collected for 
evaluating bacterial contamination and amylase lev-
els on POD1, 3, and 7 routinely. Removal of the in-
tra-abdominal drainage tube was considered after 
confirmation of no sign of abnormal infection. In 
cases where infectious POPF developed, contrast 
computed tomography was performed to evaluate 
the abdominal abscess, and the exchange of a drain-
age tube was considered more than 14 days after 
surgery.
Definition of early intra-abdominal infection and sur-
gical outcomes
In the present study, IAI was defined as intra-
abdominal infection within 3 days after PD, which 
was diagnosed by the presence of bacteria in surgical 
site drainage fluid. Additionally, POPF was defined 
as pancreatic fistula grade B or C by ISGPF12).　
Postoperative complications, such as incisional SSI, 
POPF, postoperative hemorrhage, delayed gastric 
emptying, and pneumonia, were prospectively noted 
and categorized as grade I to grade V, according to 
the modified Clavien-Dindo classification13). Post-
operative complications of grade II or above were in-
vestigated in the present study.
Statistical analysis
Descriptive statistics were produced for demo-
graphic, clinical, and laboratory characteristics for 
the study subjects. Continuous variables are re-
ported as the mean ± standard deviation (SD), and 
the values for the different subgroups were com-
pared using the unpaired t-test. Categorical vari-
ables were expressed as prevalence, and differences 
in the proportion of the different patient groups were 
compared by the chi-square test. The whole study 
proceeded in two parts. Part 1 was conducted to 
determine the factors associated with IAI, in which 
the primary outcome was defined as IAI following 
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PD. We performed multivariate regression analy-
sis using preoperative and intraoperative variables 
to determine the factors associated with IAI. A p 
< 0.10 in the unpaired t-test and chi square test was 
set for the multivariate logistic regression analysis.　
Part 2 was conducted to assess the clinical impact of 
IAI, in which potential surrogates of postoperative 
early infection status, including IAI, serum CRP, 
WBC, and drainage amylase, were used in a multi-
variate logistic regression model for predicting 
POPF.　In the statistical analyses, a p < 0.05 was 
considered statistically significant.  We used Stata 
(version 13, STATA Corp., College Station, TX, 
USA) for all statistical analyses.
Results
Patient characteristics
During the study period, 133 patients who met 
the eligibility criteria were included. Thirteen pa-
tients had received pancreaticojejunostomy with in-
ternal drainage using a lost stent and were therefore 
excluded from the analysis. The clinicopathologic 
characteristics of the 133 patients are outlined in Ta-
ble 1. The entire study population had a mean age 
of 68.3 (SD±10.1) years, of whom 67.7% were 
male. PD was performed for pancreatic cancer in 
45 patients (33.8%), biliary duct carcinoma in 40 pa-
tients (30.1%), carcinoma of the papilla of Vater in 20 
patients (15%), and IPMN in 15 patients (11.3%).
Preoperative biliary drainage was performed in 
81 patients (60.9%) with jaundice at onset : ERBD 
using a plastic stent for 75 patients and PTBD for 
six patients. The waiting period from the primary 
biliary drainage to surgery was almost 6 weeks, and 
62% of the patients with preoperative biliary drain-
age (PBD) had cholangitis after the drainage, result-
ing in biliary stent replacement.
Composition of isolated bacteria from intra-abdominal 
drainage fluid 
IAI was observed in 48 patients (36.1%) in the 
present study. There were nine species of bacteria 
detected from surgical sites in the early phase, of 
which eight were Enterococci species (Table 2).　
The variety of bacteria isolated after POD7 in-
creased to more than 15 species, which may have 
been the result of prolonged intra-abdominal infec-
tion. With regard to the spectrum of isolated bacte-
ria after POD7, the proportions of species of Entero-
coccus or Candida remained larger ; however, gram-
negative bacillus, such as Staphylococcus, MRSA, 
Klebsiella, and pseudomonas were newly detected.　
Therefore, polymicrobial infection was characterized 
in clinically relevant POPF.
Part 1 : The factors associated with postoperative IAI 
following pancreaticoduodenectomy
The results of univariate and multivariate analy-
ses using pre- and intra-operative variables with po-
tential relationships to IAI are reported in Table 3.　
The univariate analysis showed that higher patient 
age (p = 0.001), PBD (p < 0.001), lower prothrom-
bin time (p = 0.037), soft pancreas (p < 0.001), and 
biliary duct carcinoma (p < 0.001) were significantly 
related to the development of IAI. The multivari-
ate logistic regression analysis showed that the in-
dependent associated factors were soft pancreas (p 
= 0.001), patient age (p = 0.009), and PBD (p = 
0.023). 
Table 1.  Baseline characteristics of the study popula-
tion.
Variables All patients (n = 133)
Mean age, years (SD)  68.3 (10.1)
Male sex, n (%)  90 (67.7)
Mean BMI, kg/m2 (SD)  22.4 (3.6)
Pathological diagnosis, n (%)
 pancreatic adenocarcinoma  45 (33.8)
 biliary duct carcinoma  40 (30.1)
 Vater papillary carcinoma  20 (15.0)
 intrapapillary mucinous neoplasm  15 (11.3)
 duodenum cancer   7 (5.3)
 pancreatic neuroendocrine tumor   3 (2.3)
 others   3 (2.3)
Comorbidity, n (%)
 diabetes mellitus  37 (27.8)
Type of PBD, n (%)
 none  52 (39.1)
 ERBD  75 (56.4)
 PTBD   6 (4.5)
Cholangitis after BD, n (%)  32 (24.1)
Mean operation time, min (SD) 541.1 (122.4)
Mean blood loss, mL (SD) 780.8 (748.4)
Intraoperative transfusion, n (%)  21 (15.91)
Vascular reconstruction, n (%)   6 (4.51)
Soft pancreas  75 (56.82)
Abbreviations : SD, standard deviation ; BMI, body 
mass index ; ASA, American society of Anesthesiolo-
gists ;  PBD, preoperative biliary drainage ; ERBD, en-
doscopic retrograde biliary drainage ; PTCD, percutane-
ous transhepatic biliary drainage ; BD, biliary drainage.
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Table 2. Results of bacterial culture of drainage fluid.
Isolated bacterial species Within POD3 After POD7
No. of patients 48  63
Polymicrobial infection, n (%) 13 (27.0)  40 (71.7)
Gram-positive bacilli
 Enterococcus sp. 45 (78.9)  68 (43.0)
 Staphylococcus sp.  1 (1.8)  13 (8.2)
 MRSA  1 (1.8)   6 (3.8)
 Streptococcus sp.  0   8 (5.1)
 Clostridium sp.  0   2 (1.3)
Gram-negative bacilli
 Enterobacter sp.  1 (1.8)   5 (3.2)
 Bacillus sp.  2 (3.5)   2 (1.3)
 Citrobacter sp.  1 (1.8)   3 (1.9)
 Lactococcus sp.  1 (1.8)   1 (0.6)
 Klebsiella sp.  0  10 (6.3)
 Pseudomonas sp.  1 (1.8)   5 (3.1)  
 Bacteroides sp.  0   3 (1.9)
 E. coli  0   2 (1.3)
Candida sp.  4 (7.0)  13 (8.2)
Others  0  17 (10.8)
Total 57 158
Abbreviations : POD, postoperative day ; PD, pancreaticoduodenectomy ; 
MRSA, methicillin-resistant Staphylococcus aureus.
Table 3. The factors associated with postoperative early intraabdominal infection.
Univariate analysis Multivariate analysis
Variables IAI (n = 48) 
non-IAI
 (n = 85) p value OR 95% CI p value
Male sex, n (%)  37 (77.1)  53 (62.4) 0.08 2.44 0.89-6.72 0.084
Age, yrs (SD)  72.1 (7.33)  66.2 (10.9) 0.001 1.09 1.03-1.16 0.004
BMI, kg/m2 (SD)  22.5 (3.54)  22.3 (3.7) 0.75
DM, n (%)   9 (18.8)  28 (32.9) 0.08 0.46 0.15-1.36 0.16
PBD, n (%) <0.001 2.91 1.16-7.33 0.023
 None   8 (16.7)  44 (51.8)
 ERBD  39 (81.3)  36 (42.4)
 PTBD   1 (2.1)   5 (5.9)
Cholangitis after PBD, n (%)  18 (37.5)  14 (16.5) 0.006
Serum albumin, g/dL (SD)   3.8 (0.46)   3.8 (0.50) 0.66
Total bilirubin, mg/dL (SD)   1.28 (1.55)   0.96 (0.72) 0.12
Prothrombin time, n (%)  95.3 (13.1) 100.4 (13.3) 0.037 0.96 0.93-1.00 0.061
Serum creatinine, mg/dL (SD)   0.84 (0.55)   0.75 (0.20) 0.19
Preoperative CRP, mg/dl (SD)   0.72 (1.68)   0.43 (0.75) 0.18
Soft pancreas, n (%)  39 (81.3)  36 (42.4) <0.001 8.67 2.37-31.77 0.001
BDC, n (%)  33 (68.7)  27 (31.8) <0.001 0.96 0.31-2.96 0.94
Operation time, min (SD) 566.8 (152.3) 526.4 (99.5) 0.068 1.00 0.99-1.01 0.12
Intraoperative transfusion, n (%)  11 (22.9)  10 (11.9) 0.096 0.86 0.25-3.00 0.81
Abbreviations : OR, odds ratio ; CI, confidence interval ; BMI, body mass index ; DM, diabetes mellitus ; PBD, Preop-
erative biliary drainage ; ERBD, endoscopic retrograde biliary drainage ; PTBD, percutaneous transhepatic biliary 
drainage ; CRP, c reactive protein ; BDC, Biliary duct carcinoma ; SD, standard deviation.
Continuous variables are reported as means and standard deviation, which were analyzed by Student’s t-test. Categori-
cal variables were analyzed by the chi square test.
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Part 2 : Clinical impact of IAI on postoperative pan-
creatic fistula
The postoperative complications are shown in 
Table 4. The overall rates of IAI, POPF grades B 
or C, and mortality were 36.1%, 36.1% and 0%, re-
spectively. Major complications defined as Clavien-
Dindo classification 3a or above were observed in 
30.8% of the patients. The rates of infectious com-
plications such as incisional SSI and POPF (grade B 
or C) were significantly higher in the IAI group than 
in the non-IAI group. Interestingly, 13 of the 85 
patients (15.3%) with non-IAI had POPF postopera-
tively, of whom 10 patients (76.92%) had a soft pan-
creas, high levels of drain amylase (mean, 5,385.8 g/
dL) and serum CRP (18.2 mg/dL), as shown in Table 
5.
In order to assess the clinical impact of IAI on 
clinically relevant POPF, multivariate logistic regres-
sion analysis using potential surrogates related to 
early infection status was performed, in which the 
cut-off values of continuous variables were deter-
mined via receiver operating characteristic analysis 
(Table 6). Among the potential surrogates, the sig-
nificant factors for POPF (Grade B or C) were CRP 
on POD3 of 18 mg/dL or greater (Odds ratio = 5.81, 
CI = 2.05-16.43, p = 0.001), IAI (Odds ratio = 9.46, 
CI = 3.17-28.26, p < 0.001), and drain amylase 
POD3 of 583 mg/dL or greater (Odds ratio = 6.72, 
CI = 2.28-19.81, p = 0.001). When combining IAI 
and serum CRP on POD3, 31 of 35 patients (88.57%) 
with IAI and serum CRP on POD3 (≥ 18 mg/dL) had 
POPF, whereas seven of 66 patients (10.61%) with 
non-IAI and serum CRP (< 18 mg/dL)  (Table 7) had 
POPF.
Discussion
The present study demonstrated that indepen-
dent factors associated with IAI following PD were 
PBD, soft pancreas, and patient age (Results of 
Study, Part 1). IAI has a highly negative effect on 
clinically relevant POPF, requiring longer manage-
ment of infection control. We believe that a combi-
nation of serum CRP levels (>18 mg/dL) and pres-
ence of IAI is useful for predicting complicated 
Table 4. Surgical outcome according to early intraabdominal infection.




 (n = 85) P value OR 95% CI
Incisional SSI, n (%) 18 (13.5) 12 (25.0)  6 (7.1) <0.01 3.54 1.42-8.83
Pancreatic fistula, Grade B/C, n (%) 48 (36.1) 35 (72.9) 13 (15.3) <0.01 4.77 2.81-8.10
Postoperative hemorrhage, n (%)  6 (4.5)  4 (8.3)  2 (2.4)   0.11 3.54 0.67-18.6
Delayed gastric emptying, n (%) 14 (10.5)  5 (10.4)  9 (10.6)   0.98 0.98 0.35-2.77
Pneumonia, n (%)  1 (0.75)  1 (2.1)  0   0.18 - -
Clavien-Dindo 3a, n (%) 41 (30.8) 26 (54.2) 15 (17.6) <0.01 3.07 1.81-5.20
90-day mortality, n (%)  0 (0) - - - - -
Abbreviations : IAI, early intraabdominal infection ; OR, odds ratio ; CI, confidence interval ; SSI, surgical site infection 
Table 5. Difference in characteristics between the POPF and non-POPF groups in patients with non-IAI.
Variables




 (n = 72) p value
Mean age, years (SD)    67.2 (12.5)  66.0 (10.7) p = 0.444
Male, n (%)     9 (69.23)  44 (61.11) p = 0.578
Mean BMI, Kg/m2 (SD)    24.8 (3.92)  21.8 (3.49) p = 0.008
PBD, n (%)     5 (38.46)  36 (50.00) p = 0.444
Soft pancreas, n (%)    10 (76.92)  26 (36.11) p = 0.006
Drain amylase on POD3, g/dL (SD) 5,385.8 (13,096.4) 767.73 (1,599.1) p = 0.004
Serum CRP on POD3, mg/dL (SD)    18.2 (4.5)  12.5 (6.4) p = 0.003
Abbreviations : POPF, postoperative pancreatic fistula ; BMI, body mass index ; PBD, preoperative biliary drainage ; 
POD3, postoperative day 3 ; CRP, C-reactive protein.
The unpaired t-test was used to compare the mean values of the different subgroups, and the chi-square test was used for 
testing the relationships between categorical variables.
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tus20,21) in jaundice patients. However, PBD has 
many drawbacks, such as biliary stent-induced bac-
terial contamination and cholangitis due to obstruc-
tion of the biliary duct stent. According to two re-
cent meta-analyses22,23), opinions were divided about 
whether PBD for patients with malignant obstruc-
tive jaundice has a beneficial effect on postoperative 
outcome or not. In terms of avoiding biliary infec-
tion, preoperative stenting of the common bile duct 
may be restricted on the basis of clear indication, 
such as cholangitis, severe symptomatic jaundice, or 
neoadjuvant chemotherapy.
With regard to preoperative biliary infection 
control, the method of biliary stenting must be dis-
cussed. ERBD using a plastic stent is associated 
with an increased incidence of cholangitis due to its 
lower patency24). In the present study, ERBD using 
a plastic stent was performed in over 90% of the BD 
patients. Furthermore, 70% of the patients with 
ERBD developed cholangitis while waiting for sur-
gery and had biliary stent replacement. A meta-
analysis investigating the safety and efficacy of naso-
biliary drainage versus biliary stenting in malignant 
biliary obstruction suggested that endoscopic naso-
biliary drainage has merit in terms of not only pre-
operative cholangitis but also postoperative pancre-
atic fistula25). Another promising approach for 
controlling IAI may be the prophylactic administra-
tion of antimicrobial agents for preoperative biliary 
Table 6.  Multivariate logistic regression analysis using potential sur-
rogate markers of postoperative early infection status.
Variables OR 95% CI p value
  IAI (yes vs. no) 9.46 3.17-28.26 <0.001
  CRP on POD3, mg/dL
(< 18 vs ≥ 18) 5.81 2.05
-16.43 0.001
  Drain amylase, g/dL
(< 583 vs ≥ 583) 6.72 2.28
-19.81 0.001
  WBC on POD3, /μL 
(< 9,300 vs ≥ 9,300) 1.74 0.59
-5.15 0.319
Abbreviations : OR, odds ratio ; CI, confidence interval ; CRP, C-re-
active protein ; POD3, postoperative day 3 ; WBC, white blood 
count ; IAI, early intra-abdominal infection.
Cut-off values of CRP on POD3, drain amylase, and WBC were deter-
mined by receiver operating characteristic analysis to predict postop-
erative pancreatic fistula.
Table 7. Occurrence of POPF (grade B or C) according to infection status on POD3.
Serum CRP on POD3 Non-IAI (−), n=85 IAI (+), n=48
<18 mg/dL 10.61% (7/66) 28.57% (4/13)
≧ 18 mg/dL 31.58% (6/19) 88.57% (31/35)
Abbreviations : POPF, postoperative pancreatic fistula ; POD, postoperative day.
POPF in the postoperative early phase (Results of 
Study, Part 2).
Soft pancreas is a widely recognized risk factor 
for anastomotic leakage of pancreaticojejunostomy 
or pancreaticogastrostomy. A previous study on a 
series of nearly 2,000 pancreaticoduodenectomies 
showed that soft pancreas was associated with a 
pancreatic fistula rate of 22.6, leading to a 10-fold in-
creased risk of pancreas fistula compared to inter-
mediate or hard pancreatic parenchyma14). It has 
been widely accepted that fragile pancreatic paren-
chyma due to soft pancreas makes anastomosis diffi-
cult to perform. Moreover, the amount of pancre-
atic juice secretion is higher in patients with soft 
pancreas than in patients with hard pancreas.　
Thus, there is a strong association between pancre-
atic texture and pancreatic leakage containing enter-
ic bacteria. This could explain the results of the 
present study indicating that soft pancreas was an 
independent associated factor for IAI.
Our finding that PBD has an association with 
the development of surgical site infections is consis-
tent with the findings of previous studies8,15-17). In 
the past decade, the pros and cons of PBD for pa-
tients with jaundice due to periampullary cancer 
have been discussed. Since the 1980s, hyperbiliru-
binemia has been recognized as a risk factor for poor 
surgical outcome18,19). Evidence suggests that PBD 
can improve immune functions and nutritional sta-
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bacterial contamination. A randomized controlled 
trial conducted by Okamura et al. demonstrated that 
preoperative bile culture-targeted administration of 
prophylactic antibiotics decreased surgical site infec-
tions in hepato-biliary-pancreatic surgery with bili-
ary reconstruction26).
In the present study, we could visualize the risk 
levels of POPF via the potential surrogates of post-
operative early infection status (Table 6). Although 
IAI, serum CRP, and drain amylase were significant-
ly associated with POPF, IAI had the most negative 
impact on POPF (Odds ratio : 9.46). We proposed 
that the combination of IAI and serum CRP levels 
(>18 mg/dL) can provide additional information to 
predict the development of clinically relevant POPF 
(Table 7), which may be of importance for making 
decisions for postoperative management, such as 
those of drain tube removal and administration of 
antibiotics. We believe that removal of the drain-
age tube in the early phase should not be performed 
in patients with IAI and high serum CRP.
Surveillance of bacteria isolated from the intra-
abdominal surgical site is important for controlling 
intra-abdominal infection following PD. In the 
present study, we found that the most commonly 
isolated bacteria in IAI patients were Enterococcus 
species, under the prophylactic administration of ce-
phem antibiotics. In cases of Enterococcus infec-
tion, administration of an antimicrobial agent to 
which the species is susceptible is crucial for infec-
tion control, due to its inherent resistance to ce-
phem antibiotics. Interestingly, prevalence of poly-
microbial infection was increased in intra-abdominal 
infection after POD7 (40 of 63 patients ; 76.9%), 
compared to IAI (13 of 48 patients ; 27%), in which 
the isolated bacteria resistant to multiple antibiotics 
may be increased, thereby making infection control 
difficult. Therefore, controlling the initial infection 
is crucial for postoperative management of PD, 
avoiding development of polymicrobial infection and 
the subsequent prolonged intra-abdominal infection.　
On the basis of our finding that Enterococcus spe-
cies was isolated at a frequency of 78.9% in IAI pa-
tients, Gram staining may provide key information 
to determine which bacteria is responsible for post-
operative intra-abdominal infection, although it takes 
a few days to incubate samples for testing bacterium.
When interpreting the clinical significance of 
IAI on postoperative outcome, it should be noted 
that POPF could be complicated even in non-IAI pa-
tients. In the present study, POPF was complicat-
ed in 13 (15.3%) of 85 patients initially diagnosed 
with non-IAI (Table 4). Characteristics of non-IAI 
patients developing POPF are higher BMI (24.8 Kg/
m2), soft pancreas (76.92%), high levels of amylase 
in drain fluid (5,385.8 g/dL), and serum CRP (18.2 
mg/dl) on POD3 (Table 5). Therefore, we suggest 
that early removal of the drainage tube might not be 
determined only by absence of IAI. Indeed, in the 
present study, removal of the drainage tube within 
POD5 was not performed in non-IAI patients with 
POPF because of the high levels of amylase in the 
drainage fluid and serum CRP on POD3.
There are several limitations to the current 
study. First, the number of subjects was relatively 
small, and the study population was heterogenous in 
primary diagnosis for surgery. In the interpretation 
of the findings of the present study, the difference in 
prevalence of bile duct carcinoma between Western 
countries and East Asia should be taken into consid-
eration. In East Asia, the proportion of patients 
with bile duct carcinoma, many of whom have a soft 
pancreas, is higher than that in Western countries.　
Second, the path of the bacteria causing the IAI was 
not fully examined in this study. In order to deter-
mine whether the bacterial species are derived from 
preoperative bacterial contamination of the bile duct, 
identification of microorganisms in preoperative and 
intraoperative bile juice is necessary.
Conclusions
The present study demonstrated that preopera-
tive BD, soft pancreas, and higher age were factors 
associated with IAI, and that IAI has a significantly 
negative impact on postoperative outcome. Efforts 
to control IAI must be pursued to enhance the safety 
of PD.
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